Publicacións en colaboración con investigadores/as de New York University School of Medicine (23)

2021

  1. Annexin A2-Mediated Plasminogen Activation in Endothelial Cells Contributes to the Proangiogenic Effect of Adenosine A2A Receptors

    Frontiers in Pharmacology, Vol. 12

2015

  1. Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors

    Arthritis Research and Therapy, Vol. 17, Núm. 1

  2. Promotion of Wound Healing by an Agonist of Adenosine A2A Receptor Is Dependent on Tissue Plasminogen Activator

    Inflammation, Vol. 38, Núm. 6, pp. 2036-2041

2014

  1. β-Adrenoceptors differentially regulate vascular tone and angiogenesis of rat aorta via ERK1/2 and p38

    Vascular Pharmacology, Vol. 61, Núm. 2-3, pp. 80-89

2009

  1. Adenosine receptor agonists for promotion of dermal wound healing

    Biochemical Pharmacology

2006

  1. Adenosine A 2A receptors play a role in the pathogenesis of hepatic cirrhosis

    British Journal of Pharmacology, Vol. 148, Núm. 8, pp. 1144-1155

  2. Adenosine A2A receptors in diffuse dermal fibrosis: Pathogenic role in human dermal fibroblasts and in a murine model of scleroderma

    Arthritis and Rheumatism, Vol. 54, Núm. 8, pp. 2632-2642

  3. Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis

    Arthritis Research and Therapy, Vol. 8, Núm. 2

2005

  1. Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1

    Molecular Pharmacology, Vol. 67, Núm. 5, pp. 1406-1413

  2. Genetically based resistance to the antiinflammatory effects of methotrexate in the air-pouch model of acute inflammation

    Arthritis and Rheumatism, Vol. 52, Núm. 8, pp. 2567-2575

2004

  1. Adenosine A2A receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis

    American Journal of Pathology, Vol. 164, Núm. 6, pp. 1887-1892

  2. Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages

    Journal of Leukocyte Biology, Vol. 76, Núm. 3, pp. 727-734

  3. Interferon-γ impedes reverse cholesterol transport and promotes foam cell transformation in THP-1 human monocytes/macrophages

    Medical Science Monitor, Vol. 10, Núm. 11

2003

  1. Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68

    Arthritis and Rheumatism, Vol. 48, Núm. 1, pp. 240-247

  2. Th1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells

    Journal of Immunology, Vol. 171, Núm. 8, pp. 3991-3998

2002

  1. Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin gel)

    Inflammation, Vol. 26, Núm. 1, pp. 19-24

  2. Non-prostaglandin effects of aspirin III and salicylate: Inhibition of integrin-dependent human neutrophil aggregation and inflammation in COX 2- and NFκB (P105)-knockout mice

    Advances in Experimental Medicine and Biology

  3. Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A2A receptor agonists and endotoxin

    American Journal of Pathology, Vol. 160, Núm. 6, pp. 2231-2244

2001

  1. Adenosine mediates the antiinflammatory effects of methotrexate as well as its toxicities

    Drug Development Research

  2. Immune complexes and IFN-γ decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages

    Journal of Lipid Research, Vol. 42, Núm. 11, pp. 1913-1922